A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2-D liquid separations, protein microarrays, and tandem mass spectrometry

Tasneem H. Patwa, Yanfei Wang, Fred R. Miller, Steven Goodison, Subramaniam Pennathur, Timothy J. Barder, David M. Lubman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

An analysis of phosphorylation changes that occur during cancer progression would provide insights into the molecular pathways responsible for a malignant phenotype. In this study we employed a novel coupling of 2-D liquid separations and protein microarray technology to reveal changes in phosphoprotein status between premalignant (AT1) and malignant (CA1a) cell lines derived from the human MCF10A breast cell lines. Intact proteins were first separated according to their pI and hydrophobicities, then arrayed on SuperAmine glass slides. Phosphoproteins were detected using the universal, inorganic phospho-sensor dye, Pro-Q Diamond. Using this dye, out of 140 spots that were positive for phosphorylation, a total of 85 differentially expressed spots were detected over a pH range of 7.2-4.0. Proteins were identified and their peptides sequenced by MS. The strategy enabled the identification of 75 differentially expressed phosphoproteins, from which 51 phosphorylation sites in 27 unique proteins were confirmed. Interestingly, the majority of differentially expressed phosphorylated proteins observed were nuclear proteins. Three regulators of apoptosis, Bad, Bax, and Acinus, were also differentially phosphorylated in the two cell lines. Further development of this strategy will facilitate an understanding of the mechanisms involved in malignancy progression and other disease-related phenotypes.

Original languageEnglish (US)
Pages (from-to)51-66
Number of pages16
JournalProteomics - Clinical Applications
Volume3
Issue number1
DOIs
StatePublished - May 14 2009
Externally publishedYes

Fingerprint

Protein Array Analysis
Phosphoproteins
Microarrays
Tandem Mass Spectrometry
Mass spectrometry
Breast
Cells
Phosphorylation
Cell Line
Liquids
Proteins
Coloring Agents
Phenotype
Diamond
Nuclear Proteins
Hydrophobic and Hydrophilic Interactions
Glass
Disease Progression
Neoplasms
Hydrophobicity

Keywords

  • Breast cancer
  • Liquid chromatography
  • Phosphorylation
  • Protein microarray
  • Tandem mass spectrometry

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2-D liquid separations, protein microarrays, and tandem mass spectrometry. / Patwa, Tasneem H.; Wang, Yanfei; Miller, Fred R.; Goodison, Steven; Pennathur, Subramaniam; Barder, Timothy J.; Lubman, David M.

In: Proteomics - Clinical Applications, Vol. 3, No. 1, 14.05.2009, p. 51-66.

Research output: Contribution to journalArticle

@article{af2685b61ef744bcb5600c5a49083444,
title = "A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2-D liquid separations, protein microarrays, and tandem mass spectrometry",
abstract = "An analysis of phosphorylation changes that occur during cancer progression would provide insights into the molecular pathways responsible for a malignant phenotype. In this study we employed a novel coupling of 2-D liquid separations and protein microarray technology to reveal changes in phosphoprotein status between premalignant (AT1) and malignant (CA1a) cell lines derived from the human MCF10A breast cell lines. Intact proteins were first separated according to their pI and hydrophobicities, then arrayed on SuperAmine glass slides. Phosphoproteins were detected using the universal, inorganic phospho-sensor dye, Pro-Q Diamond. Using this dye, out of 140 spots that were positive for phosphorylation, a total of 85 differentially expressed spots were detected over a pH range of 7.2-4.0. Proteins were identified and their peptides sequenced by MS. The strategy enabled the identification of 75 differentially expressed phosphoproteins, from which 51 phosphorylation sites in 27 unique proteins were confirmed. Interestingly, the majority of differentially expressed phosphorylated proteins observed were nuclear proteins. Three regulators of apoptosis, Bad, Bax, and Acinus, were also differentially phosphorylated in the two cell lines. Further development of this strategy will facilitate an understanding of the mechanisms involved in malignancy progression and other disease-related phenotypes.",
keywords = "Breast cancer, Liquid chromatography, Phosphorylation, Protein microarray, Tandem mass spectrometry",
author = "Patwa, {Tasneem H.} and Yanfei Wang and Miller, {Fred R.} and Steven Goodison and Subramaniam Pennathur and Barder, {Timothy J.} and Lubman, {David M.}",
year = "2009",
month = "5",
day = "14",
doi = "10.1002/prca.200800097",
language = "English (US)",
volume = "3",
pages = "51--66",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2-D liquid separations, protein microarrays, and tandem mass spectrometry

AU - Patwa, Tasneem H.

AU - Wang, Yanfei

AU - Miller, Fred R.

AU - Goodison, Steven

AU - Pennathur, Subramaniam

AU - Barder, Timothy J.

AU - Lubman, David M.

PY - 2009/5/14

Y1 - 2009/5/14

N2 - An analysis of phosphorylation changes that occur during cancer progression would provide insights into the molecular pathways responsible for a malignant phenotype. In this study we employed a novel coupling of 2-D liquid separations and protein microarray technology to reveal changes in phosphoprotein status between premalignant (AT1) and malignant (CA1a) cell lines derived from the human MCF10A breast cell lines. Intact proteins were first separated according to their pI and hydrophobicities, then arrayed on SuperAmine glass slides. Phosphoproteins were detected using the universal, inorganic phospho-sensor dye, Pro-Q Diamond. Using this dye, out of 140 spots that were positive for phosphorylation, a total of 85 differentially expressed spots were detected over a pH range of 7.2-4.0. Proteins were identified and their peptides sequenced by MS. The strategy enabled the identification of 75 differentially expressed phosphoproteins, from which 51 phosphorylation sites in 27 unique proteins were confirmed. Interestingly, the majority of differentially expressed phosphorylated proteins observed were nuclear proteins. Three regulators of apoptosis, Bad, Bax, and Acinus, were also differentially phosphorylated in the two cell lines. Further development of this strategy will facilitate an understanding of the mechanisms involved in malignancy progression and other disease-related phenotypes.

AB - An analysis of phosphorylation changes that occur during cancer progression would provide insights into the molecular pathways responsible for a malignant phenotype. In this study we employed a novel coupling of 2-D liquid separations and protein microarray technology to reveal changes in phosphoprotein status between premalignant (AT1) and malignant (CA1a) cell lines derived from the human MCF10A breast cell lines. Intact proteins were first separated according to their pI and hydrophobicities, then arrayed on SuperAmine glass slides. Phosphoproteins were detected using the universal, inorganic phospho-sensor dye, Pro-Q Diamond. Using this dye, out of 140 spots that were positive for phosphorylation, a total of 85 differentially expressed spots were detected over a pH range of 7.2-4.0. Proteins were identified and their peptides sequenced by MS. The strategy enabled the identification of 75 differentially expressed phosphoproteins, from which 51 phosphorylation sites in 27 unique proteins were confirmed. Interestingly, the majority of differentially expressed phosphorylated proteins observed were nuclear proteins. Three regulators of apoptosis, Bad, Bax, and Acinus, were also differentially phosphorylated in the two cell lines. Further development of this strategy will facilitate an understanding of the mechanisms involved in malignancy progression and other disease-related phenotypes.

KW - Breast cancer

KW - Liquid chromatography

KW - Phosphorylation

KW - Protein microarray

KW - Tandem mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=65549128783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549128783&partnerID=8YFLogxK

U2 - 10.1002/prca.200800097

DO - 10.1002/prca.200800097

M3 - Article

VL - 3

SP - 51

EP - 66

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 1

ER -